392 related articles for article (PubMed ID: 27678434)
1. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
de Souza JA; Vindis C; Hansel B; Nègre-Salvayre A; Therond P; Serrano CV; Chantepie S; Salvayre R; Bruckert E; Chapman MJ; Kontush A
Atherosclerosis; 2008 Mar; 197(1):84-94. PubMed ID: 17868679
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
Hansel B; Girerd X; Bonnefont-Rousselot D; Bittar R; Chantepie S; Orsoni A; Bruckert E; Chapman MJ; Kontush A
Am J Cardiovasc Drugs; 2011 Oct; 11(5):317-25. PubMed ID: 21699274
[TBL] [Abstract][Full Text] [Related]
4. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
5. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
[TBL] [Abstract][Full Text] [Related]
7. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
[TBL] [Abstract][Full Text] [Related]
8. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Atherosclerosis; 2005 Oct; 182(2):277-85. PubMed ID: 16159600
[TBL] [Abstract][Full Text] [Related]
9. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
10. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
[TBL] [Abstract][Full Text] [Related]
12. Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.
Hansel B; Kontush A; Bonnefont-Rousselot D; Bruckert E; Chapman MJ
Curr Atheroscler Rep; 2006 Nov; 8(6):501-9. PubMed ID: 17045077
[TBL] [Abstract][Full Text] [Related]
13. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.
Scheffer PG; Tushuizen ME; Vermue HP; Schindhelm RK; Rustemeijer C; Diamant M
Eur J Clin Nutr; 2011 Nov; 65(11):1242-9. PubMed ID: 21712838
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL.
Cho KH; Nam HS; Kang DJ; Zee S; Park MH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674667
[TBL] [Abstract][Full Text] [Related]
15. Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome.
Khan AA; Mundra PA; Straznicky NE; Nestel PJ; Wong G; Tan R; Huynh K; Ng TW; Mellett NA; Weir JM; Barlow CK; Alshehry ZH; Lambert GW; Kingwell BA; Meikle PJ
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):438-447. PubMed ID: 29284607
[TBL] [Abstract][Full Text] [Related]
16. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
17. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
Barkas F; Elisaf M; Liberopoulos E; Liontos A; Rizos EC
Atherosclerosis; 2016 Apr; 247():58-63. PubMed ID: 26868509
[TBL] [Abstract][Full Text] [Related]
18. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
19. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipid composition and LDL oxidation.
Brizzi P; Tonolo G; Carusillo F; Malaguarnera M; Maioli M; Musumeci S
Clin Chem Lab Med; 2003 Jan; 41(1):56-60. PubMed ID: 12636050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
